As previously reported, Barclays analyst Charles Pitman-King downgraded Dialight (DIALF) to Underweight from Equal Weight with a EUR 60 price target as the firm transferred coverage of European Life Sciences to a new analyst. The firm cites reimbursement headwinds to the diagnostics subsector, competition headwinds in the respiratory franchise and below-consensus growth forecasts for its downgrade.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DIALF: